Ligand-selective transactivation and transrepression via the glucocorticoid receptor: Role of cofactor interaction

Molecular and Cellular Endocrinology

Volumn 299, Issue 2, 2009, Pages 219-231

  Ronacher, Katharina ^a   Hadley, Katie ^b   Avenant, Chanel ^b   Stubsrud, Elisabeth ^a   Simons Jr , S Stoney ^c   Louw, Ann ^a   Hapgood, Janet P ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cofactor; Glucocorticoid receptor; Transactivation; Transrepression

Indexed keywords

GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; STEROID; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; RECEPTOR BINDING; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALS; BINDING, COMPETITIVE; CARRIER PROTEINS; CELL LINE; DEXAMETHASONE; DNA; HUMANS; LIGANDS; NERVE TISSUE PROTEINS; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 58949097528     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.10.008     Document Type: Article

References (56)

1. Adcock I.M., Nasuhara Y., Stevens D.A., and Barnes P.J. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-{kappa}B and lack of I-{kappa}B involvement. Br. J. Pharmacol. 127 (1999) 1003-1011
2. An J., Tzagarakis-Foster C., Scharschmidt T.C., Lomri N., and Leitman D.C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem. 276 (2001) 17808-17814
3. Baek S.H., Ohgi K.A., Nelson C.A., Welsbie D., Chen C., Sawyers C.L., Rose D.W., and Rosenfeld M.G. Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. PNAS 103 (2006) 3100-3105
4. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Lambert M.H., Moore J.T., Pearce K.H., and Xu H.E. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 (2002) 93-105
5. Chen S., Sarlis N.J., and Simons Jr. S.S. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription. J. Biol. Chem. 275 (2000) 30106-30117
6. Chen W., Rogatsky I., and Garabedian M.J. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol. Endocrinol. 20 (2006) 560-572
7. Cheng S., Brzostek S., Lee S.R., Hollenberg A.N., and Balk S.P. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Mol. Endocrinol. 16 (2002) 1492-1501
8. Cho S., Blackford Jr. J.A., and Simons Jr. S.S. Role of activation function domain-1, DNA-binding and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes. Biochemistry 44 (2005) 3547-3561
9. Cho S., Kagan B.L., Blackford Jr. J.A., Szapary D., and Simons Jr. S.S. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9. Mol. Endocrinol. 19 (2005) 290-311
10. Coghlan M.J., Jacobson P.B., Lane B., Nakane M., Lin C.W., Elmore S.W., Kym P.R., Luly J.R., Carter G.W., Turner R., Tyree C.M., Hu J., Elgort M., Rosen J., and Miner J.N. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17 (2003) 860-869
11. Cvoro A., Tzagarakis-Foster C., Tatomer D., Paruthiyil S., Fox M.S., and Leitman D.C. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol. Cell 21 (2006) 555-564
12. De Bosscher K., Berghe W.V., Beck I.M.E., Van Molle W., Hennuyer N., Hapgood J., Libert C., Staels B., Louw A., and Haegeman G. A fully dissociated compound of plant origin for inflammatory gene repression. PNAS 102 (2005) 15827-15832
13. Dewint P., Gossye V., De Bosscher K., Vanden Berghe W., Van Beneden K., Deforce D., Van Calenbergh S., Muller-Ladner U., Vander Cruyssen B., Verbruggen G., Haegeman G., and Elewaut D. A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J. Immunol. 180 (2008) 2608-2615
14. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., and Stallcup M.R. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12 (1998) 302-313
15. Garside H.J., Stevens A., Farrow S., Normand C., Houle B., Berry A., Maschera B., and Ray D.W. Glucocorticoid ligands specify different interactions with NF-KB by allosteric effects on the glucocorticoid receptor DNA binding domain. J. Biol. Chem. 279 (2004) 50050-50059
16. Giannoukos G., Szapary D., Smith C.L., Meeker J.E.W., and Simons Jr. S.S. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties. Mol. Endocrinol. 15 (2001) 255-270
17. Hayashi R., Wada H., Ito K., and Adcock I.M. Effects of glucocorticoids on gene transcription. Eur. J. Pharmacol. 500 (2004) 51-62
18. He Y., and Simons Jr. S.S. STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression. Mol. Cell Biol. 27 (2007) 1467-1485
19. He Y., Szapary D., and Simons Jr. S.S. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation. J. Biol. Chem. 277 (2002) 49256-49266
20. Hultman M.L., Krasnoperova N.V., Li S., Du S., Xia C., Dietz J.D., Lala D.S., Welsch D.J., and Hu X. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms. Mol. Endocrinol. 19 (2005) 1460-1473
21. Jaber B.M., Gao T., Huang L., Karmakar S., and Smith C.L. The pure estrogen receptor antagonist ICI 182 780 promotes a novel interaction of estrogen receptor-{Alpha} with the 3′,5′-cyclic adenosine monophosphate response element-binding protein-binding protein/P300 coactivators. Mol. Endocrinol. 20 (2006) 2695-2710
22. Kang Z., Janne O.A., and Palvimo J.J. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol. 18 (2004) 2633-2648
23. Kauppi B., Jakob C., Farnegardh M., Yang J., Ahola H., Alarcon M., Calles K., Engstrom O., Harlan J., Muchmore S., Ramqvist A.K., Thorell S., Ohman L., Greer J., Gustafsson J.A., Carlstedt-Duke J., and Carlquist M. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a conformation that leads to active antagonism. J. Biol. Chem. 278 (2003) 22748-22754
24. Kim Y., Sun Y., Chow C., Pommier Y.G., and Simons Jr. S.S. Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. J. Steroid Biochem. Mol. Biol. 100 (2006) 3-17
25. Koubovec D., Ronacher K., Stubsrud E., Louw A., and Hapgood J.P. Synthetic progestins used in HRT have different glucocorticoid agonist properties. Mol. Cell Endocrinol. 242 (2005) 23-32
26. Kroe R.R., Baker M.A., Brown M.P., Farrow N.A., Gautschi E., Hopkins J.L., LaFrance R.R., Kronkaitis A., Freeman D., Thomson D., Nabozny G., Grygon C.A., and Labadia M.E. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor. Biophys. Chem. 128 (2007) 156-164
27. Kumar R., and Thompson E.B. Gene regulation by the glucocorticoid receptor: structure:function relationship. J. Steroid Biochem. Mol. Biol. 94 (2005) 383-394
28. Li X., Wong J., Tsai S.Y., Tsai M.J., and O'Malley B.W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell Biol. 23 (2003) 3763-3773
29. Liu Z., Auboeuf D., Wong J., Chen J.D., Tsai S.Y., Tsai M.J., and O'Malley B.W. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. PNAS 99 (2002) 7940-7944
30. Louw A., Swart P., de Kock S.S., and van der Merwe K.J. Mechanism for the stabilization in vivo of the aziridine precursor 2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride by serum proteins. Biochem. Pharmacol. 53 (1997) 189-197
31. Miner J.N. Designer glucocorticoids. Biochem. Pharmacol. 64 (2002) 355-361
32. Miner J.N., Ardecky B., Benbatoul K., Griffiths K., Larson C.J., Mais D.E., Marschke K., Rosen J., Vajda E., Zhi L., and Negro-Vilar A. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. PNAS 104 (2007) 19244-19249
33. Miner J.N., Tyree C., Hu J., Berger E., Marschke K., Nakane M., Coghlan M.J., Clemm D., Lane B., and Rosen J. A nonsteroidal glucocorticoid receptor antagonist. Mol. Endocrinol. 17 (2003) 117-127
34. Ozers M.S., Marks B.D., Gowda K., Kupcho K.R., Ervin K.M., DeRosier T., Qadir N., Eliason H.C., Riddle S.M., and Shekhani M.S. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Biochemistry 46 (2007) 683-695
35. Padron A., Li L., Kofoed E.M., and Schaufele F. Ligand-selective interdomain conformations of estrogen receptor-{alpha}. Mol. Endocrinol. 21 (2007) 49-61
36. Peterson T.J., Karmakar S., Pace M.C., Gao T., and Smith C.L. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor {alpha} transcriptional activity. Mol. Cell Biol. 27 (2007) 5933-5948
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29 (2001) e45
38. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353 (2005) 1711-1723
39. Rogatsky I., Zarember K.A., and Yamamoto K.R. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO 20 (2001) 6071-6083
40. Rogatsky I., Luecke H.F., Leitman D.C., and Yamamoto K.R. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. PNAS 99 (2002) 16701-16706
41. Simons Jr. S.S. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. Bioessays 30 (2008) 744-756
42. Shiau A.K., Barstad D., Radek J.T., Meyers M.J., Nettles K.W., Katzenellenbogen B.S., Katzenellenbogen J.A., Agard D.A., and Greene G.L. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat. Struct. Mol. Biol. 9 (2002) 359-364
43. Song L.N., Huse B., Rusconi S., and Simons Jr. S.S. Transactivation specificity of glucocorticoid versus progesterone receptors. Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains. J. Biol. Chem. 276 (2001) 24806-24816
44. Sui X., Bramlett K.S., Jorge M.C., Swanson D.A., von Eschenbach A.C., and Jenster G. Specific androgen receptor activation by an artificial coactivator. J. Biol. Chem. 274 (1999) 9449-9454
45. Sun Y., Tao Y., Kagan B.L., He Y., and Simons Jr. S.S. Modulation of Transcription Parameters in Glucocorticoid Receptor-Mediated Repression. Mol. Cell. Endocrinol. 295 (2008) 59-69
46. SuwwandeFelipe K., Carter B.T., Althoff E.A., and Cornish V.W. Correlation between ligand-receptor affinity and the transcription readout in a yeast three-hybrid system. Biochemistry 43 (2004) 10353-10363
47. Szapary D., Huang Y., and Simons Jr. S.S. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol. Endocrinol. 13 (1999) 2108-2121
48. Szapary D., Song L.N., He Y., and Simons Jr. S.S. Differential modulation of glucocorticoid and progesterone receptor transactivation. Mol. Cell Endocrinol. 283 (2008) 114-126
49. Tao Y., Xu Y., Xu H.E., and Simons Jr. S.S. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression. Biochemistry 47 (2008) 7648-7662
50. Wang D., Wang Q., Awasthi S., and Simons Jr. S.S. Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors. Biochemistry 46 (2007) 8036-8049
51. Wang D., and Simons Jr. S.S. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate. Mol. Endocrinol. 19 (2005) 1483-1500
52. Wang J.C., Shah N., Pantoja C., Meijsing S.H., Ho J.D., Scanlan T.S., and Yamamoto K.R. Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev. 20 (2006) 689-699
53. Wang Q., Anzick S., Richter W.F., Meltzer P., and Simons Jr. S.S. Modulation of transcriptional sensitivity of mineralocorticoid and estrogen receptors. J. Steroid Biochem. Mol. Biol. 91 (2004) 197-210
54. Wang Q., Blackford Jr. J.A., Song L.N., Huang Y., Cho S., and Simons Jr. S.S. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors. Mol. Endocrinol. 18 (2004) 1376-1395
55. Wu J., Li Y., Dietz J., and Lala D.S. Repression of P65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions. Mol. Endocrinol. 18 (2004) 53-62
56. Yoon H.G., and Wong J. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol. Endocrinol. 20 (2006) 1048-1060